公司资料
iTeos Therapeutics 股价、新闻与催化剂
- 股票代码:
- ITOS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Belgium and listed in the U
股价为何变动
Current closing-price context is not available for ITOS.
公司概览
业务概览
iTeos Therapeutics is an immuno-oncology company developing therapies that modulate the tumor microenvironment. Its pipeline is aimed at creating better cancer immunotherapy combinations.
所在地与行业分类
Headquartered in Belgium and listed in the U.S. as an ADR, iTeos has a global oncology-biotech profile.
商业模式特征
The business depends on clinical data, partnership economics, and the ability to create differentiated oncology assets.
生物医药行业定位
iTeos is a catalyst-heavy immuno-oncology name whose stock reacts quickly to data and strategic developments.
未来催化剂
- iTeos Therapeutics's catalysts are belrestotug and the rest of its immuno-oncology pipeline, where the next clinical update will determine whether the platform still has momentum. The company remains very data-sensitive.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。